Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.75 |
| ▸ | HTR2C | P28335 | 1/20 | 0.75 |
| ▸ | HTR2B | P41595 | 1/20 | 0.75 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.73 |
| ▸ | TUBB | P07437 | 3/20 | 0.73 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.73 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.73 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.73 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.73 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.73 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.73 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.73 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.73 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.73 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.73 |
| ▸ | TUBB6 | Q9BUF5 | 3/20 | 0.73 |
| ▸ | TUBB2B | Q9BVA1 | 3/20 | 0.73 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.73 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7424861 | 0.90 | HTR2A (0.69) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL8864538 | 0.89 | HTR2A (0.62) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL2500546 | 0.88 | PTGS2 (0.68) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL29286367 | 0.87 | TUBB4A (0.74) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL20696534 | 0.87 | TUBB4A (0.74) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL21530612 | 0.87 | TUBB4A (0.70) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL30079962 | 0.87 | TUBB4A (0.74) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL29689431 | 0.87 | TUBB4A (0.74) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| Mescaline SCHEMBL25170531 | 0.86 | HTR2A (1.00) | HTR2AHTR2CHTR2BTUBB4ATUBB | |
| SCHEMBL3127096 | 0.86 | HTR2A (0.64) | HTR2AHTR2CHTR2BTUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022236790-A1 | APPLICATION OF EXTRACT OF DENDROBIUM CAPILLIPES RCHB.F., DENDROBIUM LINDLEYI STENDEL AND DENDROBIUM SECUNDUM(BLUME)LINDL. AS α-GLUCOSIDASE INHIBITOR | 中国热带农业科学院热带生物技术研究所 | 2022-11-17 | — | — | WO | claimed |
| CN-118771956-A | Carboxylic acid decarboxylation coupling conversion method using sulfur hexafluoride as oxidizing reagent | 国网安徽省电力有限公司电力科学研究院 | 2024-10-15 | — | — | CN | disclosed |
| WO-2022236790-A1 | APPLICATION OF EXTRACT OF DENDROBIUM CAPILLIPES RCHB.F., DENDROBIUM LINDLEYI STENDEL AND DENDROBIUM SECUNDUM(BLUME)LINDL. AS α-GLUCOSIDASE INHIBITOR | 中国热带农业科学院热带生物技术研究所 | 2022-11-17 | — | — | WO | disclosed |
| US-7528271-B2 | Intermediates, process for their preparation and synthesis of 1,4-benzoquiones | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2009-05-05 | — | — | US | disclosed |
| WO-2008140328-A2 | NOVEL INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND SYNTHESIS OF 1,4-BENZOQUINONES | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2008-11-20 | — | — | WO | disclosed |
| US-20080287702-A1 | Novel intermediates, process for their preparation and synthesis of 1, 4-benzoquiones | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2008-11-20 | — | — | US | disclosed |
| EP-0154887-B1 | NEW 2,5-DIARYL TETRAHYDROTHIOPHENES AND ANALOGS THEREOF AS PAF-ANTAGONISTS | MERCK & CO. INC. (US) | 1989-01-25 | — | — | EP | disclosed |
| EP-0199324-A2 | New 2,5-diaryl tetryhydrofurans and analogs thereof as paf antagonists | MERCK & CO. INC. (US) | 1986-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287702-A1 | Novel intermediates, process for their preparation and synthesis of 1, 4-benzoquiones | SQOR, NDUFB10, UQCRB | HTR2A 1559/4885HTR2C 1778/4885HTR2B 1065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.